MiNK Therapeutics
INKT
INKT
34 hedge funds and large institutions have $800K invested in MiNK Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$36.2K | |
| 2 | +$3.16K | |
| 3 | +$814 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$651 |
| 5 |
Goldman Sachs
New York
|
+$488 |
Top Sellers
| 1 | -$682K | |
| 2 | -$368K | |
| 3 | -$143K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$107K |
| 5 |
VF
Virtu Financial
New York
|
-$30K |